Strict sodium intake — with or without restrictions on fluid intake — is unlikely to confer clinical benefits on patients with heart failure, reported investigators. Their...
Over the past 30 years, chronic kidney disease has become one of the leading causes of death and years of healthy life lost in Latin America....
Chamundi Selvaraj takes a weekly dose of Ozempic because she’s afraid of dying from diabetes-related kidney failure like her mother and four aunts, who all passed...
STOCKHOLM — In the treatment of type 2 diabetes, sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide 1 receptor agonists (GLP-1 RAs) show independent benefits that...
The use of semaglutide for non-diabetic obese patients with cardiovascular disease was first reported to be associated with significant benefit in the SELECT trial, where major...